24 November 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce the University Hospital in Münster (UKM), Germany has signed a purchase agreement with Imricor, marking the ninth site the Company has contracted this year.

Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR guided cardiac ablation products, is pleased to announce the Schleswig-Holstein University Medical Centre (Universitätsklinikum Schleswig-Holstein, or UKSH), in Lübeck Germany, has signed a purchase agreement with Imricor. The Company is working with the Lübeck University Heart Centre, which is under the umbrella of UKSH, to schedule installation, training, and first procedures.

26 October 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in iCMR guided cardiac ablation products, is pleased to announce the Jaques Cartier Private Hospital’s Institut Cardiovasculaire Paris Sud (ICPS) has signed a purchase agreement with Imricor. The Company is working with the site to schedule installation, training, and first procedures.

28 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce the Rhön Clinic Bad Neustadt Campus in Bad Neustadt an der Saale, Germany has signed a purchase agreement with Imricor. The Company is working with the site to schedule installation, training, and first procedures.

27 September 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided ablation products, is pleased to announce it was awarded a contract from the US National Insitutues of Health (NIH) to develop an MRI comptabile myocardial biopsy system. Under the agreement, Imricor will receive US$399,539 over the next 12 months to develop a prototype system of devices that biopsy the inner walls of the heart, while using MR imaging to guide the procedure.

Imricor Medical Systems Inc (ASX:IMR) chair and CEO Steve Wedan speaks to Proactive’s Andrew Scott at the virtual ASX Small and Mid-Cap Conference 2020.

12 August 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) the global leader in MRI-guided cardiac ablation products, is pleased to announce a sales collaboration with Optoacoustics Ltd, the world leader in innovative, high performance optical communication solutions for magnetic resonance (MR) applications.

23 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce the first procedure using the Company’s products in a traditional diagnostic MRI lab have been performed at the Amsterdam University Medical Center.

5 June 2020 – Minneapolis, United States – Imricor Medical Systems, Inc. (Company or Imricor) (ASX:IMR) is pleased to announce, the first two successful cardiac catheter ablation procedures using the Company’s product at the Haga Hospital. These procedures are a first for heart care in the Benelux.